NEOGENIX ONCOLOGY Trademark

Trademark Overview

On Monday, August 3, 2009, a trademark application was filed for NEOGENIX ONCOLOGY with the United States Patent and Trademark Office. The USPTO has given the NEOGENIX ONCOLOGY trademark a serial number of 77795852. The federal status of this trademark filing is CANCELLED - SECTION 18 as of Thursday, May 26, 2016. This trademark is owned by Neogenix Oncology, Inc.. The NEOGENIX ONCOLOGY trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic and therapeutic monoclonal antibodies, and vaccines, for the diagnosis and treatment of, and immunization to, cancers
neogenix oncology

General Information

Serial Number77795852
Word MarkNEOGENIX ONCOLOGY
Filing DateMonday, August 3, 2009
Status713 - CANCELLED - SECTION 18
Status DateThursday, May 26, 2016
Registration Number3851325
Registration DateTuesday, September 21, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 5, 2010

Trademark Statements

Disclaimer with Predetermined Text"ONCOLOGY"
Goods and ServicesDiagnostic and therapeutic monoclonal antibodies, and vaccines, for the diagnosis and treatment of, and immunization to, cancers
Pseudo MarkNEO GENICS ONCOLOGY

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code3 - Sec. 18 - Entire Registration
Class Status DateThursday, May 26, 2016
Primary Code005
First Use Anywhere DateTuesday, December 15, 2009
First Use In Commerce DateTuesday, December 15, 2009

Trademark Owner History

Party NameNeogenix Oncology, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressGreat Neck, NY 11021
Party NameNeogenix Oncology, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreat Neck, NY 11021
Party NameNeogenix Oncology, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreat Neck, NY 11021

Trademark Events

Event DateEvent Description
Thursday, May 26, 2016CANCELLED SECTION 18-TOTAL
Thursday, May 26, 2016CANCELLATION TERMINATED NO. 999999
Wednesday, May 25, 2016CANCELLATION GRANTED NO. 999999
Saturday, January 16, 2016CANCELLATION INSTITUTED NO. 999999
Tuesday, September 21, 2010REGISTERED-PRINCIPAL REGISTER
Thursday, August 19, 2010NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, August 18, 2010LAW OFFICE REGISTRATION REVIEW COMPLETED
Wednesday, August 18, 2010ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, August 16, 2010STATEMENT OF USE PROCESSING COMPLETE
Tuesday, July 20, 2010USE AMENDMENT FILED
Monday, August 16, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 20, 2010TEAS STATEMENT OF USE RECEIVED
Tuesday, March 30, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 5, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 5, 2010PUBLISHED FOR OPPOSITION
Monday, November 30, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, November 30, 2009ASSIGNED TO LIE
Wednesday, November 11, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 11, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 11, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 11, 2009EXAMINER'S AMENDMENT ENTERED
Wednesday, November 11, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, November 11, 2009EXAMINERS AMENDMENT E-MAILED
Wednesday, November 11, 2009EXAMINERS AMENDMENT -WRITTEN
Thursday, November 5, 2009ASSIGNED TO EXAMINER
Friday, August 7, 2009NOTICE OF PSEUDO MARK MAILED
Thursday, August 6, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 6, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

oncology neogenix treatment immunization cancers diagnosis vaccines therapeutic monoclonal antibodies diagnostic